FDA Inspection 1158795 — AMICUS THERAPEUTICS
The FDA completed an inspection of AMICUS THERAPEUTICS on Nov 5, 2021 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)